SCHEMBL7918679

SCHEMBL7918679

CCCC(I)(c1ccc(Cl)cc1)c1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.43
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
POLB P06746 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MIF P14174 1/20 0.39
KIF11 P52732 1/20 0.39
BCL2 P10415 1/20 0.38
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
HIF1A Q16665 1/20 0.37
NPSR1 Q6W5P4 2/20 0.36
LMNA P02545 1/20 0.35
CYP2A6 P11509 1/20 0.35
AR P10275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6700733 0.78 ESR1 (0.38) POLBESR1ESR2LMNAAR
SCHEMBL7339642 0.77 KCNN4 (0.41) MEN1KMT2ASMN1; SMN2KIF11ESR1
SCHEMBL12936023 0.76 MEN1 (0.48) CYP19A1MEN1KMT2APOLBSMN1; SMN2
Iodide SCHEMBL28547565 0.76 KCNN4 (0.40) MEN1KMT2ASMN1; SMN2KIF11ESR1
SCHEMBL10253668 0.74 KMT2A (0.58) CYP19A1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL11028937 0.74 MEN1 (0.41) CYP19A1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL13824285 0.74 MEN1 (0.52) MEN1KMT2APOLBSMN1; SMN2L3MBTL1
SCHEMBL7034676 0.74 MEN1 (0.46) CYP19A1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL7041297 0.74 KMT2A (0.44) CYP19A1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL12054100 0.72 ESR1 (0.46) CYP19A1MEN1KMT2APOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140791-A4 SELECTIVE CPLA 2 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2001-10-10 EP disclosed
EP-1140791-A2 SELECTIVE CPLA 2 INHIBITORS Bristol-Myers Squibb Company (US) 2001-10-10 EP disclosed
WO-1999015129-A2 SELECTIVE cPLA2 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-04-01 WO disclosed